JASMINA TERZIC: Open Payments
NPI 1962154690 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 63 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $1,315
Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $160 |
| ABBVIE INC. | 8 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $140 |
| Lundbeck LLC | 5 | $125 |
| Axsome Therapeutics, Inc. | 5 | $116 |
| Janssen Pharmaceuticals, Inc | 4 | $105 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Almatica Pharma LLC | 4 | $69 |
| Tris Pharma Inc | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
Products named: REXULTI, ARISTADA, VRAYLAR, CAPLYTA, Auvelity, SPRAVATO, LOREEV XR, Jornay PM.
Industry payments across FL — which companies pay providers there.
